Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

OrganoTex® textile impregnation is launched in the UK with FTUK as agent

OrganoClick is since two years supplying fluorocarbon-free and biodegradable textile impregnations and maintenance products for clothes and garments under the brand OrganoTex®. The products are sold in Sweden, Finland and Norway in stores like Naturkompaniet, Partioaitta, Alewalds, Skistar, Team Sportia, among others. OrganoTex® is now launched in the UK with the sport and outdoor agent FTUK as sales partner.[OrganoTex product family]  OrganoTex ® Textile Waterproofing Spray-On and Wash-In has been developed during several years and have been designed to give good water repellancy,

This year's edition of the Baltic Sea Festival has been cancelled

The Baltic Sea Festival, which was to take place in August 2020, has been cancelled.  Even though it had been intended to make the festival a digital project, the planning conditions due to the Covid-19 outbreak have finally made that impossible. "We had prepared to present the festival digitally, even though the circumstances would have been difficult.  Since the outbreak of covid-19 prevented physical audiences in Berwaldhallen, we have anyway continued to present live concerts every week on P2 as well as web-streamed on Berwaldhallen Play;  we were pleased with the positive

XMReality Remote Guidance to be used by Iristick smart glasses

XMReality AB and Iristick NV have entered a partnership to offer XMReality Remote Guidance together with Iristick’s smart glasses. Iristick smart glasses are specifically built for industrial applications and hence meet safety glasses standards. XMReality Remote Guidance can now be integrated with the glasses to solve complex problems faster and more efficient and will be part of Iristick’s offer.This collaboration allows field service engineers and operators to use XMReality Remote Guidance together with Iristick.Z1 smart glasses to get remote assistance. Smart glasses provide a handsfree

Neste MY Renewable Diesel available at more than 200 sales points in Sweden by year-end

Neste Corporation, Press Release, 27 May 2020 at 10 a.m. (EET)  Neste, the world’s largest producer of renewable diesel and the 3rd most sustainable company in the world*, deepens its partnership with one of Sweden’s largest fuel companies, OKQ8. Neste MY Renewable Diesel ™, produced from renewable and sustainable raw materials, will become available at 130 OKQ8 network stations by the end of 2020, also for private customers. The total Neste MY Renewable Diesel sales points in Sweden will more

NENT Group appoints new CEO for refocused Studios operations

· Alexander Bastin appointed as SVP and CEO of NENT Studios from 1 September · Morten Mogensen appointed as SVP and Head of NENT Studios businesses that are currently being sold · Extended Group Executive Management team will now comprise five SVPs Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, today announced changes to the leadership of its NENT Studios businesses. Alexander Bastin has been appointed as SVP and CEO of NENT Studios from 1 September, while Morten Mogensen has been appointed from the same date as SVP and Head of the NENT

Demonstrating strong customer focus and therapeutic expertise, TFS CRO has been awarded new Covid-19 studies.

TFS is working in collaboration with sponsors, at an unprecedented pace. Our operational teams are participating in various studies, targeting coronavirus disease patients or analyzing the real world evidence to bring treatments to COVID-19 patients faster. TFS is continuously recognized for agility as well as the knowledge and experience of our teams. In-depth expertise in the field of internal medicine as well as strong presence in Spain allow TFS to partner with customers on four more trials on Covid-19. The studies total up to more than 3300 patients in 17 sites covering full a

Nordea Economic Outlook: Long time to heal economic scars

The outlook for the world economy remains bleak. The COVID-19 pandemic has evolved into the biggest health crisis in 100 years, and the draconian measures to curb the spread of infection have had enormous financial costs. While economic growth will soon be on the rise again as locked-down communities gradually reopen, it will likely be a long time before the economic scars have fully healed. The Nordic economies have also been hit hard by the containment measures and global recession. However, thanks to good public finances, they are relatively well equipped to deal with the long-term

Scandion Oncology announces that the first patient has received treatment with SCO-101 in combination with FOLFIRI.

Scandion Oncology A/S (“Scandion Oncology”) is pleased to announce that the first patient has received treatment with SCO-101 and FOLFIRI with no unexpected SCO-101-related events observed. By measuring an exposure biomarker during treatment, it was observed that SCO-101 caused the expected changes in the level of this exposure biomarker, demonstrating that SCO-101 was present in the body in an effective concentration.Due to the COVID-19 pandemic most activities around clinical trials have been on hold or slowed down in Denmark for a couple of months. However, as COVID-19 is now under

Redsense Medical selects Etteplan to further develop and industrialize their medical device

Etteplan press release May 27, 2020 at 9.45 a.m. EEST Redsense Medical trusts Etteplan in further developing and industrializing their hose clamp used in hemodialysis treatment. The project includes industrialization of a prototype previously developed by Etteplan in order to launch the product on the market. Redsense Medical and Etteplan have been cooperating for many years within the medtech area and the development of medical devices. Etteplan has previously supported Redsense in the development of a blood loss detection device. The device is used for monitoring and alarm in the

Notice of the Annual General Meeting in Realfiction Holding AB (publ)

The shareholders of Realfiction Holding AB (publ), reg. no 559110-4616 (”the Company”) are hereby summoned to the Annual General Meeting on Thursday, 25 June 2020.  In light of the coronavirus, the Annual General Meeting is conducted through advance voting pursuant to temporary regulations. Therefore, it will not be possible to attend this year’s Meeting in person or by proxy.RIGHT TO PARTICIPATEThose wishing to participate in the Annual General Meeting must be registered as shareholders in the share register maintained by Euroclear Sweden AB as of Thursday, 18 June 2020. NOTIFICATION

Cantargia publishes interim report for first quarter 2020

Cantargia AB’s (”Cantargia”) interim report for first quarter 2020 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the first quarter · Cantargia advanced its development of CAN04 by successfully scaling up production. · Cantargia completed a directed share issue which raised SEK 410 million before transaction costs. · Cantargia acquired a patent portfolio from Cellerant Therapeutics Inc. that includes a US patent on IL1RAP as target for antibody therapy in leukemia. Significant events after the end of the period

Alfa Laval signs agreement for waste heat recovery units – newly developed for land-based applications

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has signed an agreement with a Chinese system builder for the delivery of land-based waste heat recovery units. Alfa Laval has supplied large marine waste heat recovery systems for a long time. This newly developed unit – Alfa Laval Micro – is much smaller in size and specifically targets land-based applications. The frame agreement signals the market’s early acceptance of the new solution.The agreement stretches over two years and comprises the delivery of Alfa Laval Micro units to power plants in

The Board of Directors of Recipharm resolves on a rights issue of approximately SEK 2,017 million and announces the terms

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.  The Board of Directors of Recipharm AB (publ) (”Recipharm”, the ”Company” or the ”Group”) has, with the support of the authorisation from the Annual General Meeting on 12 May 2020,

Prominent US healthcare provider Sanford Health expands its Sectra Enterprise Imaging Solution

Linköping, Sweden and Shelton, CT – May 27, 2020 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a contract with Sanford Health to add cardiology to their existing enterprise imaging solution. All physicians throughout the 44-medical center system will have access to radiology and cardiology images on one workstation, all fully integrated with Epic Radiant and Cupid.“We are honored to see Sanford Health add cardiology into their Sectra solution. We look forward to a continued close partnership as Sanford takes this next step

First in the world – an ECG-necklace as a medical device revolutionises the self-monitoring of the heart rhythm

Heart2Save and Lumoava, both from Finland, decided to combine their expertise; the result is a new generation medical device – an ECG-necklace, AiVoni 💗 Lumoava. The beautiful design, combined with reliable arrhythmia analysis enables you to monitor the well-being of your heart in a stylish, unnoticeable way – at home, at work, on holiday – no matter where you are. New products for the identification and screening of arrhythmias are being developed at high speed all over the world. The consumer experience is vital, the products must be easy and practical to use in everyday life. Stylish

Redsense obtains MDR registration on what would have been the regulation’s first day of application

On 26 May 2020, the same day as the original date of application of the EU’s new Medical Device Regulation (MDR), Redsense Medical became one of the first companies to achieve compliance with the new regulations as the Company obtained its confirmation of registration. The revised legal framework for medical devices in the EU was adopted in 2017, and was originally intended to enter into force on 26 May 2020 after a transitional period. The date of mandatory application was recently postponed one year due to the COVID-19 crisis to relieve the pressure on affected parties, and the rules

Annual General Meeting in AQ Group AB (publ) on June 25, 2020

The Annual General Meeting in AQ Group AB (publ) will be held on Thursday, June 25, 2020 at 18:00 in Västerås, Sweden. Those who register for the meeting will receive more detailed information about the place.   Notice of the Annual General Meeting, with proposed agenda is included in its entirety in this press release and is published on the company web page www.aqg.se . The notice of the meeting is published in "Post- och Inrikes Tidningar" and an announcement with information that the

Interim report for the period January 1 - March 31, 2020

Baseload Capital Sweden AB (publ) today releases the results for the period 1 January – 31 March 2020.During the first quarter of 2020, the company continued to develop projects in Japan, Taiwan and Iceland. Covid-19 has so far had limited effect on the company; the impact on ongoing projects has led to some delays in some of the projects, but the work has largely been able to proceed as planned. However, travel restrictions mean temporarily less focus on business development. · The result for the period was SEK -8.3 million (SEK 9.9 million for the same period in 2019). · During

Getinge develops digital platform together with Semcon to reduce the risk of infection during surgeries

Getinge has partnered with Semcon to develop a new digital platform that will easily identify where the greatest risks for infections are during surgeries.In Sweden, infections are the most common hospital injuries – a problem that is widespread even globally. According to an estimate by the European Centre for Disease Prevention and Control, there are nearly 9 million cases of health care associated infections in European hospital and long-term care each year. "The project aims at helping health care facilities to reduce the number of health care associated infections that can occur

Tele2 and Civil Rights Defenders partner to secure reliable connectivity for human rights defenders’ security alarms globally

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) and Civil Rights Defenders have entered a partnership in which Tele2 provides IoT connectivity to the global security system of Civil Rights Defenders’ Natalia Project, protecting human rights defenders all over the world. Civil Rights Defenders’ Natalia Project was created in 2013 to promote freedom of speech and protect human right defenders in countries where threats, or even attacks, might be used to silence outspoken voices. In short, each participating human rights defender is provided with security training

Digital platform to reduce the risk of infections during surgery

One in ten people in hospital care develops a healthcare-related infection. Together with Getinge, Semcon is developing a new digital platform to make it easier to identify where the risk of infections during surgery is greatest.In Sweden, infections are the most common form of injury as a result of treatment in hospitals – a problem that is also widespread globally. According to an estimate from the European Centre for Disease Prevention and Control, there are nearly 9 million cases of healthcare-related infections in European hospitals and long-term care every year.  “The digital

Optomed’s January–March 2020 interim report to be published on Friday 29 May 2020

Optomed Plc        Press Release       27 May 2020 at 9.00, Helsinki Optomed’s January–March 2020 interim report to be published on Friday 29 May 2020 Optomed will publish its January–March 2020 interim report on Friday 29 May 2020 approximately at 9.00 EEST. A telephone conference for analysts, investors and media will be arranged on the publishing day at 14.00 EEST. The event will be held in English. The presentation material will be available at www.optomed.com/investors 13.00 EEST at the latest. The participants are requested to register for the call in advance by email to

There are no items matching the current filter
There are no more items matching the current filter
Back to top